Mary Brunkow speaks at an event Tuesday at Seattle’s Institute for Systems Biology celebrating her 2025 Nobel Prize in Physiology or Medicine. (ISB Photo / Alex Garland) The groundbreaking immunology ...
Benzinga’s Edge Stock Rankings system scores stocks across key measures including momentum, growth, value and quality. The momentum score serves as a key indicator for traders looking to capitalize on ...
A California biotech tycoon has been found guilty of orchestrating a murder-for-hire plot to kill a father of six and former business partner after their oil deal collapsed. Serhat Gumrukcu, 42, of ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Every year, thousands of biotech breakthroughs stall. Not because the science failed, but ...
Sutro Biopharma was once worth $1 billion, another Bay Area biotech company with deep coffers and a novel research plan. And now, like at so many of its peers, the layoffs are stacking up. After ...
Oct 1 (Reuters) - Biotechnology firm Galapagos' (GLPG.AS), opens new tab board has received non-binding offers from several groups, mainly comprised of financial investors, for its cell therapy ...
An international biotechnology company that is headquartered in Connecticut is laying off 68 employees in the state. PerkinElmer U.S. LLC is permanently closing its manufacturing facility at 710 ...
Genmab’s $8 billion all-cash acquisition of Merus, advised by A&O Shearman, Latham & Watkins, NautaDutilh and Kromann Reumert, is one of the largest European biotech deals to date. A&O Shearman, ...
A Dallas biotech company is working on something that sounds straight out of science fiction: bringing back extinct animals. The company just opened its new global headquarters in Dallas, where more ...
Despite a challenging year, the biotech industry has continued to push boundaries, taking bold risks in pursuit of groundbreaking science. If anything, this year has only strengthened our conviction ...
UniQure's experimental gene therapy offers hope for Huntington's disease, using a medical device by ClearPoint Neuro An experimental gene therapy by UniQure has shown to slow the progress of ...
ProPhase Labs Inc. (Nasdaq: PRPH), a biotech firm with plans to build a crypto treasury, announced on Sep. 23 that its three COVID-19 testing lab units have filed for reorganization under Chapter 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback